Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, April 20, 2018 · 443,029,937 Articles · 3+ Million Readers

Retinal Vein Occlusion - Therapeutics Assessment and Pipeline Review, H2 2024

Retinal Vein Occlusion 

PUNE, MAHARASHTRA, INDIA, March 1, 2018 / -- Retinal Vein Occlusion 


Retinal vein occlusion is a blockage in one of the veins returning blood flow from the retina. The retina is where images are converted to nerve signals. The primary symptom of retinal vein occlusion is a sudden painless change in vision. Predisposing factors are atherosclerosis, macular edema, diabetes, high blood pressure, high cholesterol and age.

Click here for sample report @

Top Companies mentioned

Clearside BioMedical Inc

Formycon AG

Graybug Vision Inc

Kala Pharmaceuticals Inc

Lupin Ltd

Mabion SA

Retinal Vein Occlusion Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Retinal Vein Occlusion   - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Retinal Vein Occlusion  , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Retinal Vein Occlusion (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinal Vein Occlusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 3, 3, 9, 2 and 1 respectively.

Retinal Vein Occlusion pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Retinal Vein Occlusion - Competitive Analysis

Key players are making innovative developments in Retinal Vein Occlusion industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Retinal Vein Occlusion.

The pipeline guide reviews pipeline therapeutics for Retinal Vein Occlusion by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Retinal Vein Occlusion therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Retinal Vein Occlusion therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Retinal Vein Occlusion.


For Detailed Reading Please visit @

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Wise Guy Reports
+91 841 198 5042
email us here

Powered by EIN Presswire